Voyager Therapeutics

Home » Voyager Therapeutics

Secondary

Voyager Therapeutics

Voyager Therapeutics is a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases.

Symbol

VYGR

Last Closing Price
$13.38

Shares
4,000,000

Effective Date
November 8, 2017

Underwriters
Morgan Stanley, Cowen

To view the prospectus for Voyager Therapeutics, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253